Results 31 to 40 of about 1,807,811 (158)

An Introduction to Relevant Immunology Principles with Respect to Oral Vaccines in Aquaculture

Microorganisms, 2023
Vaccines continue to play an enormous role in the progression of aquaculture industries worldwide. Though preventable diseases cause massive economic losses, injection-based vaccine delivery is cost-prohibitive or otherwise impractical for many producers.
Evan M. Jones, Kenneth D. Cain
doaj   +1 more source

A Phase 4, multicentre, randomized, single-blind clinical trial to evaluate the immunogenicity of the live, attenuated, oral rotavirus vaccine (116E), ROTAVAC®, administered simultaneously with or without the buffering agent in healthy infants in India

Human Vaccines & Immunotherapeutics, 2018
Background: The World Health Organization recommends that rotavirus vaccines should be included in all national immunization programs. Some currently licensed oral rotavirus vaccines contain a buffering agent (either as part of a ready-to-use liquid ...
Raches Ella, Radhika Bobba, Sanjay Muralidhar, Sudhir Babji, Krishna Mohan Vadrevu, Maharaj Kishan Bhan   +5 more
doaj   +1 more source

Development and evaluation of an oral liposomal vaccine for the prevention of Edwardsiellosis in Anguilla japonica caused by Edwardsiella piscicida

Fisheries and Aquatic Sciences
Edwardsiellosis, caused by Edwardsiella piscicida infection in eels (Anguilla japonica), is a major problem for Korean eel farms, so there is an urgent need to develop a vaccine.
Young Min Woo, Keun Woo Lee, Byung-Chul Jeong, Jae Young Cha, Won-Sik Woo, Chan-Il Park, Young Jae Kim, Dong-Geun Lee, Sang-Hyeon Lee, Jun Cheul Ahn, Andre Kim   +10 more
doaj   +1 more source

Mass Production of Virus-Like Particles Using Chloroplast Genetic Engineering for Highly Immunogenic Oral Vaccine Against Fish Disease

Frontiers in Plant Science, 2021
Nervous necrosis virus (NNV) is the causative agent of viral nervous necrosis (VNN), which is one of the most serious fish diseases leading to mass mortality in a wide range of fish species worldwide.
Yoichi Nakahira, Yoichi Nakahira, Kaori Mizuno, Hirofumi Yamashita, Minami Tsuchikura, Kaoru Takeuchi, Takashi Shiina, Takashi Shiina, Hidemasa Kawakami   +8 more
doaj   +1 more source

Human saliva exerts strong type-dependent effects on adenovirus infectivity

Frontiers in Immunology
BackgroundThe development of mucosal adenovirus (Ad) vaccine vectors is considered one of the next frontiers to protect vulnerable patients from respiratory and gastrointestinal pathogens.
Erwan Sallard, Wenli Zhang, Nikita Chilakamarri, Setareh Farzanehkari, Setareh Farzanehkari, Inga Marte Charlott Seuthe, Anja Ehrhardt, Malik Aydin, Malik Aydin   +8 more
doaj   +1 more source

Development of a bivalent conjugate vaccine candidate against rotaviral diarrhea and tuberculosis using polysaccharide from Mycobacterium tuberculosis conjugated to ΔVP8* protein from rotavirus

, 2021
Conjugation of carbohydrate antigens with a carrier protein is a clinically proven strategy to overcome the poor immunogenicity of bacterial polysaccharide.
조상래
core   +1 more source

Surface Display of Avian H5 and H9 Hemagglutinin Antigens on Non-Genetically Modified Lactobacillus Cells for Bivalent Oral AIV Vaccine Development

Microorganisms
A novel bivalent oral vaccine candidate against H5N1 and H9N2 avian influenza virus (AIV) was developed using Lactobacillus surface display technology without genetic modification.
Fuyi Liu, Jingbo Chang, Jingqi Huang, Yuping Liao, Xiaonan Deng, Tingting Guo, Jian Kong, Wentao Kong   +7 more
doaj   +1 more source

Oral Vaccination Approaches for Anti-SHIV Immunity

Frontiers in Immunology, 2021
We modified a Sabin Oral Poliovirus Vaccine (OPV) vector to permit secretion of the antigens of interest with the goal of improving anti-HIV Env humoral responses in a SHIV mucosal immunization composed of DNA and recombinant OPVs.
Erandi Velarde de la Cruz, Erandi Velarde de la Cruz, Lingyun Wang, Lingyun Wang, Deepanwita Bose, Deepanwita Bose, Sailaja Gangadhara, Sailaja Gangadhara, Robert L. Wilson, Rama R. Amara, Rama R. Amara, Pamela A. Kozlowski, Anna Aldovini, Anna Aldovini   +13 more
doaj   +1 more source

Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis.

, 2005
BACKGROUND: Decisions about the use of killed oral cholera vaccines, which confer moderate levels of direct protection to vaccinees, can depend on whether the vaccines also provide indirect (herd) protection when high levels of vaccine coverage are ...
Ali, Mohammad, Sack, David A., Emch, Michael, Holmgren, Jan, Holmgren, Jan,, Clemens, John D, Rao, Malla, von Seidlein, Lorenz, Yunus, Mohammad, Clemens, John D., Sack, David A   +10 more
core   +1 more source

BCG Moreau Rio de Janeiro: an oral vaccine against tuberculosis - review

Memorias do Instituto Oswaldo Cruz, 2005
The vaccine Bacillus of Calmette Guérin (BCG) was originally developed in France as an oral vaccine against tuberculosis. The oral use of this vaccine was replaced by the parenteral route in almost all countries after the Lubeck disaster.
Thereza Christina Benévolo-de-Andrade, Renata Monteiro-Maia, Catherine Cosgrove, Luiz Roberto R Castello-Branco   +3 more
doaj   +1 more source